PT2252301E - Utilização de ulipristal para tratar fibromas uterinos - Google Patents
Utilização de ulipristal para tratar fibromas uterinos Download PDFInfo
- Publication number
- PT2252301E PT2252301E PT97063473T PT09706347T PT2252301E PT 2252301 E PT2252301 E PT 2252301E PT 97063473 T PT97063473 T PT 97063473T PT 09706347 T PT09706347 T PT 09706347T PT 2252301 E PT2252301 E PT 2252301E
- Authority
- PT
- Portugal
- Prior art keywords
- ulipristal
- uterine fibroids
- treating uterine
- treating
- fibroids
- Prior art date
Links
- 206010046798 Uterine leiomyoma Diseases 0.000 title 1
- 201000010260 leiomyoma Diseases 0.000 title 1
- 229960000200 ulipristal Drugs 0.000 title 1
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/021,610 US8299050B2 (en) | 2008-01-29 | 2008-01-29 | Method for treating uterine fibroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2252301E true PT2252301E (pt) | 2014-02-24 |
Family
ID=40551565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97063473T PT2252301E (pt) | 2008-01-29 | 2009-01-28 | Utilização de ulipristal para tratar fibromas uterinos |
Country Status (20)
| Country | Link |
|---|---|
| US (5) | US8299050B2 (https=) |
| EP (2) | EP2252301B1 (https=) |
| JP (2) | JP5906016B2 (https=) |
| KR (2) | KR101571400B1 (https=) |
| AU (1) | AU2009209652B2 (https=) |
| BR (1) | BRPI0907028B8 (https=) |
| CA (2) | CA2713254C (https=) |
| CY (1) | CY1116485T1 (https=) |
| DK (1) | DK2252301T3 (https=) |
| ES (1) | ES2450592T3 (https=) |
| HR (1) | HRP20140132T1 (https=) |
| IL (2) | IL207182A (https=) |
| MX (1) | MX2010008270A (https=) |
| NZ (1) | NZ587439A (https=) |
| PL (1) | PL2252301T3 (https=) |
| PT (1) | PT2252301E (https=) |
| SI (1) | SI2252301T1 (https=) |
| TW (1) | TWI445537B (https=) |
| WO (1) | WO2009095418A1 (https=) |
| ZA (1) | ZA201006049B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8299050B2 (en) | 2008-01-29 | 2012-10-30 | Laboratoire Hra-Pharma | Method for treating uterine fibroids |
| CN107260745A (zh) * | 2010-03-22 | 2017-10-20 | 利普生物药剂公司 | 用于抗孕酮的非毒性递送的组合物和方法 |
| EP2471537A1 (en) * | 2010-12-30 | 2012-07-04 | PregLem S.A. | Treatment of pain associated with dislocation of basal endometrium |
| EP2545922A1 (en) | 2011-07-12 | 2013-01-16 | PregLem S.A. | Treatment of excessive menstrual bleeding associated with uterine fibroids |
| EP2641602A1 (en) * | 2012-03-23 | 2013-09-25 | PregLem S.A. | Method for treating gynecological diseases |
| WO2014050105A1 (en) * | 2012-09-28 | 2014-04-03 | Aska Pharmaceutical Co., Ltd. | Amorphous ulipristal acetate |
| FR2997628B1 (fr) * | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone |
| FR2997627B1 (fr) * | 2012-11-08 | 2015-01-16 | Hra Pharma Lab | Produit de co-micronisation comprenant de l'ulipristal acetate |
| US20150320766A1 (en) * | 2012-12-14 | 2015-11-12 | Laboratoire Hra-Pharma | Copper intrauterine device |
| CN103006595B (zh) * | 2012-12-25 | 2018-04-06 | 江苏亚邦爱普森药业有限公司 | 制备醋酸优力司特片的方法 |
| US9834575B2 (en) | 2013-02-26 | 2017-12-05 | Triact Therapeutics, Inc. | Cancer therapy |
| SG11201507260QA (en) * | 2013-04-10 | 2015-10-29 | Preglem Sa | Progesteron receptor modulators for use in the therapy of uterine fibroids |
| US10444958B2 (en) * | 2013-09-23 | 2019-10-15 | Adobe Systems Incorporated | Visual example-based user interface for adjusting photos along two dimensions |
| WO2016084070A1 (en) | 2014-11-24 | 2016-06-02 | Ramot At Tel-Aviv University Ltd. | Pigment epithelium derived factor (pedf) for the treatment of uterine fibroids |
| WO2017216637A2 (en) | 2017-08-04 | 2017-12-21 | Alvogen Malta Operations (Row) Ltd | Tablet form including ulipristal acetate and the methods for its preparation |
| KR102086827B1 (ko) * | 2017-12-14 | 2020-03-10 | 경희대학교 산학협력단 | 자궁근육종 치료용 울리프리스탈 아세테이트 |
| KR102043349B1 (ko) * | 2018-01-10 | 2019-11-12 | 경희대학교 산학협력단 | 대장암 치료 용도의 울리프리스탈 아세테이트 |
| CN115460926B (zh) | 2020-02-19 | 2023-10-17 | 菲拉格私人有限责任公司 | 用于切片和针状骨去除的装置和方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954490A (en) | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
| US5468741A (en) | 1993-05-28 | 1995-11-21 | The Regents Of The University Of California | Use of low levels of mifepristone to treat leiomyomata |
| DE4426601A1 (de) | 1994-07-27 | 1996-02-01 | Schering Ag | Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri |
| WO1996023503A1 (de) | 1995-02-02 | 1996-08-08 | Schering Aktiengesellschaft | Progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen |
| US5929262A (en) | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
| AU710139B2 (en) | 1996-05-01 | 1999-09-16 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | 21-substituted progesterone derivatives as new antiprogestational agents |
| TR200001334T2 (tr) | 1997-11-14 | 2000-09-21 | Akzo Nobel N.V. | Progestojen-anti-progestojen rejimleri. |
| US6262042B1 (en) | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| FR2827517B1 (fr) | 2001-07-23 | 2003-10-24 | Bioalliance Pharma | Systemes therapeutiques bioadhesifs a liberation prolongee |
| ES2212912B1 (es) * | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
| AU2004217988C1 (en) | 2003-02-28 | 2010-06-03 | Southwest Foundation For Biomedical Research | Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| US8865200B2 (en) | 2004-07-09 | 2014-10-21 | Laboratoire Hra Pharma | Sustained release compositions containing progesterone receptor modulators |
| US20060251581A1 (en) | 2005-05-09 | 2006-11-09 | Mcintyre Jon T | Method for treatment of uterine fibroid tumors |
| AU2006294449A1 (en) | 2005-09-29 | 2007-04-05 | Repros Therapeutics Inc. | Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
| US8173626B2 (en) * | 2006-03-08 | 2012-05-08 | Danco Laboratories Llc | Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders |
| EA200970646A1 (ru) * | 2006-12-28 | 2009-12-30 | Репрос Терапьютикс Инк. | Способы и составы для улучшения биодоступности антипрогестинов |
| PT2148681E (pt) | 2007-04-20 | 2016-06-17 | Preglem Sa | Moduladores seletivos da progesterona no tratamento da hemorragia uterina |
| US8299050B2 (en) | 2008-01-29 | 2012-10-30 | Laboratoire Hra-Pharma | Method for treating uterine fibroids |
-
2008
- 2008-01-29 US US12/021,610 patent/US8299050B2/en not_active Expired - Fee Related
-
2009
- 2009-01-28 MX MX2010008270A patent/MX2010008270A/es active IP Right Grant
- 2009-01-28 DK DK09706347.3T patent/DK2252301T3/en active
- 2009-01-28 BR BRPI0907028A patent/BRPI0907028B8/pt active Search and Examination
- 2009-01-28 WO PCT/EP2009/050961 patent/WO2009095418A1/en not_active Ceased
- 2009-01-28 KR KR1020107019181A patent/KR101571400B1/ko not_active Expired - Fee Related
- 2009-01-28 HR HRP20140132AT patent/HRP20140132T1/hr unknown
- 2009-01-28 KR KR1020157011511A patent/KR20150055626A/ko not_active Ceased
- 2009-01-28 SI SI200930850T patent/SI2252301T1/sl unknown
- 2009-01-28 PL PL09706347T patent/PL2252301T3/pl unknown
- 2009-01-28 AU AU2009209652A patent/AU2009209652B2/en not_active Ceased
- 2009-01-28 PT PT97063473T patent/PT2252301E/pt unknown
- 2009-01-28 CA CA 2713254 patent/CA2713254C/en not_active Expired - Fee Related
- 2009-01-28 ES ES09706347.3T patent/ES2450592T3/es active Active
- 2009-01-28 NZ NZ587439A patent/NZ587439A/en not_active IP Right Cessation
- 2009-01-28 EP EP09706347.3A patent/EP2252301B1/en not_active Revoked
- 2009-01-28 JP JP2010544688A patent/JP5906016B2/ja not_active Expired - Fee Related
- 2009-01-28 CA CA 2857798 patent/CA2857798A1/en not_active Abandoned
- 2009-01-28 EP EP13187859.7A patent/EP2684565B1/en not_active Revoked
- 2009-02-02 TW TW098103314A patent/TWI445537B/zh not_active IP Right Cessation
-
2010
- 2010-07-25 IL IL207182A patent/IL207182A/en active IP Right Grant
- 2010-08-26 ZA ZA2010/06049A patent/ZA201006049B/en unknown
-
2012
- 2012-09-19 US US13/622,892 patent/US8722653B2/en not_active Expired - Fee Related
-
2014
- 2014-02-27 CY CY20141100158T patent/CY1116485T1/el unknown
- 2014-03-07 US US14/200,100 patent/US9180133B2/en not_active Expired - Fee Related
- 2014-08-17 IL IL234149A patent/IL234149B/en active IP Right Grant
-
2015
- 2015-01-14 JP JP2015004978A patent/JP6138838B2/ja not_active Expired - Fee Related
- 2015-10-01 US US14/872,320 patent/US9682088B2/en not_active Expired - Fee Related
-
2017
- 2017-05-16 US US15/596,746 patent/US20170246189A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201006049B (en) | Use of ulipristal for treating uterine fibroids | |
| IL215767A0 (en) | Methods of treatment for solid tumors | |
| EP2521724A4 (en) | ACTIVE AGENTS AND METHODS FOR TREATING ISCHEMIC AND OTHER DISEASES | |
| GB0803514D0 (en) | Customised surgical apparatus | |
| ZA201006648B (en) | Methods of treatment | |
| SG10201503135RA (en) | Agent for treating disease | |
| IL207892A0 (en) | Agent for treating disease | |
| ZA201109031B (en) | Compounds useful for treating aids | |
| ZA201007215B (en) | Agent for treating disease | |
| PL2473592T3 (pl) | Zastosowanie środków do traktowania twardych powierzchni | |
| ZA201204845B (en) | Agents for treating disease | |
| EP2327974A4 (en) | TISSUE TREATMENT DEVICE | |
| GB2470708B (en) | Device for morcellating tissue | |
| GB0821097D0 (en) | Surgical device | |
| EP2284515A4 (en) | APPARATUS FOR TREATING A FABRIC PIECE | |
| PL2459092T3 (pl) | Urządzenie do waporyzacji tkanek | |
| GB0921719D0 (en) | Surgical apparatus | |
| IL213287A0 (en) | Treatment for glomerulonephritis | |
| GB201204454D0 (en) | Methods of inducing tissue regeneration | |
| PL2249735T3 (pl) | Przyrząd elektrochirurgiczny | |
| PL2244572T3 (pl) | Zastosowanie kongenerów ibogaminy do leczenia otyłości | |
| GB0920933D0 (en) | Agent for treating disease | |
| GB0920942D0 (en) | Agent for treating disease | |
| GB0920940D0 (en) | Agent for treating disease | |
| HU0800656D0 (en) | Effective use of tea-composition |